True opel,
I always enjoy the transparency exhibited by management when it comes to outlook, delays and details in regards to sector being pursued for a deal.
There are many other biotech companies on the ASX which could learn a lot from our management.
Just typical consolidation going on at the moment with 2 low volume days, now followed by increasing interest yet again, which possibly precede the next wave of buying.
We saw 3 consolidation days after last spike, it appears we move on like textbook from here.
True opel,I always enjoy the transparency exhibited by...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
